Qiuyuan Wen Selected Research

Qiuyuan Wen Research Topics

Disease

27	Neoplasms (Cancer) 05/2022 - 01/2014
13	Neoplasm Metastasis (Metastasis) 06/2022 - 01/2014
11	Nasopharyngeal Carcinoma 04/2020 - 01/2014
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 05/2016
7	Lymphatic Metastasis 01/2017 - 01/2014
6	Carcinogenesis 01/2021 - 01/2017
5	Adenocarcinoma of Lung 06/2022 - 01/2019
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2022 - 01/2021
3	Lung Neoplasms (Lung Cancer) 08/2020 - 01/2015
3	Breast Neoplasms (Breast Cancer) 02/2017 - 01/2015
2	Pathologic Processes 01/2020 - 03/2019
2	Ductal Carcinoma 01/2018 - 10/2014
2	Hyperplasia 01/2018 - 01/2014
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 10/2020
1	Disease Progression 10/2019
1	Carcinoma (Carcinomatosis) 01/2017
1	Inflammation (Inflammations) 01/2017
1	Squamous Cell Carcinoma of Head and Neck 01/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2016
1	Ulcer 01/2014
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2014

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2014
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2014
6	Eukaryotic Initiation Factor-4EIBA 01/2022 - 01/2014
5	Peptide Initiation Factors (Initiation Factor)IBA 01/2022 - 01/2014
5	flotillinsIBA 04/2020 - 01/2014
4	Messenger RNA (mRNA)IBA 06/2022 - 11/2019
4	Phosphotransferases (Kinase)IBA 01/2022 - 01/2014
3	Everolimus FDA Link 01/2022 - 05/2016
3	TOR Serine-Threonine KinasesIBA 01/2021 - 05/2016
3	CGP 57380IBA 10/2019 - 05/2016
2	Small Interfering RNA (siRNA)IBA 06/2022 - 01/2015
2	CateninsIBA 01/2021 - 01/2017
2	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 01/2017
2	B7-H1 AntigenIBA 01/2021 - 10/2020
2	MicroRNAs (MicroRNA)IBA 01/2020 - 02/2017
2	Insulin Receptor Substrate ProteinsIBA 01/2018 - 01/2014
2	Paclitaxel (Taxol)FDA LinkGeneric 02/2017 - 01/2015
2	ParaffinIBA 02/2017 - 01/2017
2	Chaperonin 10IBA 01/2017 - 01/2017
2	LipidsIBA 07/2015 - 01/2015
1	jujuboside AIBA 06/2022
1	Ribosomal Protein S6IBA 05/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Metalloproteases (Metalloproteinases)IBA 01/2021
1	LigandsIBA 01/2021
1	MucinsIBA 08/2020
1	Indicators and Reagents (Reagents)IBA 08/2020
1	tyrosine receptor (receptor, tyrosine)IBA 08/2020
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2020
1	Biological ProductsIBA 12/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 02/2017
1	Untranslated RNA (Noncoding RNA)IBA 02/2017
1	Cyclin-Dependent Kinase Inhibitor p27IBA 01/2017
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2017
1	ChaperoninsIBA 01/2017
1	Cyclin D1IBA 01/2017
1	VimentinIBA 01/2017
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2017
1	Estrogens (Estrogen)FDA Link 01/2017
1	CalponinsIBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 05/2016
1	Sirolimus (Rapamycin)FDA Link 05/2016
1	MTOR InhibitorsIBA 05/2016
1	Eukaryotic Initiation Factor-4G (Eukaryotic Initiation Factor 4G)IBA 04/2016
1	DNA Methyltransferase 3AIBA 03/2016
1	Phenobarbital (Luminal)FDA Link 01/2015
1	bcl-2 Homologous Antagonist-Killer Protein (bcl 2 Homologous Antagonist Killer Protein)IBA 01/2015
1	Epidermal Growth Factor (EGF)IBA 01/2015
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 12/2014
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2014

Therapy/Procedure

5	Therapeutics 01/2022 - 05/2016
4	Radiotherapy 01/2017 - 01/2014
3	Drug Therapy (Chemotherapy) 12/2019 - 01/2014
1	Aftercare (After-Treatment) 01/2022
1	Immunotherapy 01/2021
1	Neoadjuvant Therapy 02/2017
1	Laryngectomy 01/2017